News

The company also encounters competitive risks from other organizations developing therapies for chronic kidney disease.
AES stock was surging Wednesday after a report said the renewable power company was exploring options including a potential ...
Stock futures are pointing to a slightly higher open on Wednesday after a sluggish start to the week amid uncertainty about U ...
U.S. stock futures are higher as investors eye President Donald Trump's next tariff move and minutes from the last Federal ...
Fiber weakness and macro challenges could lead to the wireless network operator underperforming, according to KeyBanc.
Follow all the latest U.S. market action for Wednesday here to see if stocks can shake of their tariff anxiety and rally to ...
Investors are digesting Trump's stiff tariffs on imports from more than a dozen countries and delayed the return of sweeping ...
Alternatively, if you seek upside with a smoother journey than a single stock like Levi Strauss, consider the High Quality ...
Shares of RxSight lost half their value in premarket trading Wednesday after the medical device maker's preliminary ...
One stock that managed to outmaneuver the various headwinds torturing the markets throughout the year, however, is data ...
Tax incentives contained in the sweeping tax and budget bill Trump signed on July 4 could provide a fresh boost to AI ...
The company’s recent cloud-services agreements should strengthen its position and improve confidence in the company’s ...